Literature DB >> 28424252

Comparison of Saramis 4.12 and IVD 3.0 Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacteria from Solid and Liquid Culture Media.

Caroline Leyer1, Guillaume Gregorowicz1, Faiza Mougari2, Laurent Raskine2, Emmanuelle Cambau2, Dominique de Briel3.   

Abstract

During the last decade, many investigators have studied matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for identification of mycobacteria. Diverse and contradictory results indicated that optimal level for routine testing has not been reached yet. This work aimed to assess Vitek MS through two distinct versions, Saramis v4.12 RUO and the IVD v3.0, under conditions close to routine laboratory practice. Overall, 111 mycobacterial isolates were subjected to protein extraction and same spectra were matched against both databases. The IVD v3.0 database proved to be superior to Saramis v4.12 and its identification rates remarkably increased, from 67% to 94% for isolates grown on Middlebrook 7H10 solid medium and from 62% to 91% for isolates grown on mycobacterial growth indicator tube (MGIT) liquid medium. With this new version, IVD v3.0, MALDI-TOF MS might be integrated into routine clinical diagnostics, although molecular techniques remain mandatory in some cases.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  MALDI-TOF mass spectrometry; Mycobacterium spp.; genotypic identification; phenotypic identification

Mesh:

Substances:

Year:  2017        PMID: 28424252      PMCID: PMC5483906          DOI: 10.1128/JCM.00006-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation.

Authors:  Jean-Hugues Salmon; Guillaume Direz; Jean-Marc Ziza; Nicole Desplaces; Pascal Brochot; Jean-Paul Eschard
Journal:  Joint Bone Spine       Date:  2012-03-10       Impact factor: 4.929

2.  Comparison of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of mycobacteria using simplified protein extraction protocols.

Authors:  Cheryl A Mather; Sheila F Rivera; Susan M Butler-Wu
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

3.  Comparison of Sample Preparation Methods, Instrumentation Platforms, and Contemporary Commercial Databases for Identification of Clinically Relevant Mycobacteria by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  Craig B Wilen; Allison R McMullen; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2015-05-13       Impact factor: 5.948

4.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Evaluation of Vitek MS for rapid classification of clinical isolates belonging to Mycobacterium avium complex.

Authors:  Daniel P Boyle; Teresa R Zembower; Chao Qi
Journal:  Diagn Microbiol Infect Dis       Date:  2014-10-02       Impact factor: 2.803

6.  Advantages of using matrix-assisted laser desorption ionization-time of flight mass spectrometry as a rapid diagnostic tool for identification of yeasts and mycobacteria in the clinical microbiological laboratory.

Authors:  Jonathan H K Chen; Wing-Cheong Yam; Antonio H Y Ngan; Ami M Y Fung; Wai-Lan Woo; Mei-Kum Yan; Garnet K Y Choi; Pak-Leung Ho; Vincent C C Cheng; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

7.  Implementation of MALDI-TOF MS technology for the identification of clinical isolates of Mycobacterium spp. in mycobacterial diagnosis.

Authors:  G Tudó; M R Monté; A Vergara; A López; J C Hurtado; M Ferrer-Navarro; J Vila; J Gonzalez-Martin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-26       Impact factor: 3.267

8.  Assessment of partial sequencing of the 65-kilodalton heat shock protein gene (hsp65) for routine identification of Mycobacterium species isolated from clinical sources.

Authors:  Alan McNabb; Diane Eisler; Kathy Adie; Marie Amos; Mabel Rodrigues; Gwen Stephens; William A Black; Judith Isaac-Renton
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  rpoB sequence-based identification of Mycobacterium avium complex species.

Authors:  Iskandar Ben Salah; Toidi Adékambi; Didier Raoult; Michel Drancourt
Journal:  Microbiology       Date:  2008-12       Impact factor: 2.777

10.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry identification of mycobacteria in routine clinical practice.

Authors:  Amel El Khéchine; Carine Couderc; Christophe Flaudrops; Didier Raoult; Michel Drancourt
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

View more
  14 in total

1.  Comparison of Two Commercial Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Systems for Identification of Nontuberculous Mycobacteria.

Authors:  Barbara A Brown-Elliott; Thomas R Fritsche; Brooke J Olson; Sruthi Vasireddy; Ravikiran Vasireddy; Elena Iakhiaeva; Diana Alame; Richard J Wallace; John A Branda
Journal:  Am J Clin Pathol       Date:  2019-09-09       Impact factor: 2.493

2.  Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics.

Authors:  Elio Cenci; Eugenio Luciano; Marika Bucaioni; Monica Rubeca; Angelica Cesarini; Silvia Bozza; Giuseppe Vittorio De Socio; Antonella Mencacci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-14       Impact factor: 3.267

3.  Evaluation of Vitek MS for Differentiation of Cryptococcus neoformans and Cryptococcus gattii Genotypes.

Authors:  Lumena P Machado Siqueira; Viviane M Favero Gimenes; Roseli Santos de Freitas; Márcia de Souza Carvalho Melhem; Lucas Xavier Bonfietti; Afonso Rafael da Silva; Letícia B Souza Santos; Adriana L Motta; Flavia Rossi; Gil Benard; João N de Almeida
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

4.  Performance of Vitek MS v3.0 for Identification of Mycobacterium Species from Patient Samples by Use of Automated Liquid Medium Systems.

Authors:  Eric Miller; Christopher Cantrell; Melodie Beard; Andrew Derylak; N Esther Babady; Tracy McMillen; Edwin Miranda; Barbara Body; Yi-Wei Tang; Ravikiran Vasireddy; Sruthi Vasireddy; Terry Smith; Elena Iakhiaeva; Richard J Wallace; Barbara A Brown-Elliott; Erik Moreno; Heather Totty; Parampal Deol
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

5.  Evaluation of the Vitek MS v3.0 Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry System for Identification of Mycobacterium and Nocardia Species.

Authors:  Barbara A Body; Melodie A Beard; E Susan Slechta; Kimberly E Hanson; Adam P Barker; N Esther Babady; Tracy McMillen; Yi-Wei Tang; Barbara A Brown-Elliott; Elena Iakhiaeva; Ravikiran Vasireddy; Sruthi Vasireddy; Terry Smith; Richard J Wallace; S Turner; L Curtis; Susan Butler-Wu; Jenna Rychert
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

6.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

7.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

8.  MALDI Spectra Database for Rapid Discrimination and Subtyping of Mycobacterium kansasii.

Authors:  Jayaseelan Murugaiyan; Astrid Lewin; Elisabeth Kamal; Zofia Bakuła; Jakko van Ingen; Vit Ulmann; Miren J Unzaga Barañano; Joanna Humięcka; Aleksandra Safianowska; Uwe H Roesler; Tomasz Jagielski
Journal:  Front Microbiol       Date:  2018-04-03       Impact factor: 5.640

9.  Evaluation of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for identifying VIM- and SPM-type metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolates.

Authors:  Jin Li; Weiwei Hu; Min Li; Shaoli Deng; Qing Huang; Weiping Lu
Journal:  Infect Drug Resist       Date:  2019-09-06       Impact factor: 4.003

10.  Rapid identification of mycobacteria from positive MGIT broths of primary cultures by MALDI-TOF mass spectrometry.

Authors:  Tsi-Shu Huang; Chia-Chien Lee; Hui-Zin Tu; Susan Shin-Jung Lee
Journal:  PLoS One       Date:  2018-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.